Articles and News Articles from the OTCMKTS, NASDAQ and NYSE markets

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70. RBC...

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70. RBC...

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70. RBC...

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70. RBC...

Shares of Abbott Laboratories (NYSE:ABT) are trading lower on Thursday following the company’s second-quarter 2024 financial results. What...

Drugmaker Ardelyx Inc (NASDAQ:ARDX) has reportedly taken legal action against the U.S. Department of Health and Human Services and the Centers for ...

Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the&n...

Delta Extraction, a Missouri-based cannabis oil manufacturer, is facing a near $20 million lawsuit following last year’s massive product reca...

Delta Extraction, a Missouri-based cannabis oil manufacturer, is facing a near $20 million lawsuit following last year’s massive product reca...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Thursday. The Dow traded down 1.08% t...